Disturbance of serotonergic neurotransmission in patients with postmyocardial infarction and depression

[1]  Jeroen J. Bax,et al.  The universal definition of myocardial infarction , 2015, Oxford Medicine Online.

[2]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[3]  B. Scirica,et al.  Acute coronary syndrome: emerging tools for diagnosis and risk assessment. , 2010, Journal of the American College of Cardiology.

[4]  J. Hernández-r,et al.  Functional change of the auditory cortex related to brain serotonergic neurotransmission in type 1 diabetic adolescents with and without depression , 2009, European Psychiatry.

[5]  Wei Jiang,et al.  Depression and heart disease: What do we know, and where are we headed? , 2009, Cleveland Clinic Journal of Medicine.

[6]  C. Villalón,et al.  5-hydroxytryptamine and cardiovascular regulation. , 2008, Trends in pharmacological sciences.

[7]  G. Manjarrez,et al.  A Functional Disturbance in the Auditory Cortex Related to a Low Serotonergic Neurotransmission in Women with Type 2 Diabetes , 2007, Neuroendocrinology.

[8]  B. Pollock,et al.  Lower Central Serotonergic Responsivity Is Associated With Preclinical Carotid Artery Atherosclerosis , 2007, Stroke.

[9]  Redford B Williams.  Lower central nervous system serotonergic function and risk of cardiovascular disease: where are we, what's next? , 2007, Stroke.

[10]  V. D. V. Sordo,et al.  La depresión tras el infarto agudo de miocardio , 2007 .

[11]  A. Robles,et al.  Prenatal impairment of brain serotonergic transmission in infants. , 2005, The Journal of pediatrics.

[12]  R. Carney,et al.  Depression following myocardial infarction. , 2005, General hospital psychiatry.

[13]  A. Robles,et al.  N1/P2 component of auditory evoked potential reflect changes of the brain serotonin biosynthesis in rats , 2005, Nutritional neuroscience.

[14]  D. Jordan.  Vagal control of the heart: central serotonergic (5‐HT) mechanisms , 2005, Experimental physiology.

[15]  D. Kemp,et al.  Heart disease and depression: don't ignore the relationship. , 2003, Cleveland Clinic journal of medicine.

[16]  D. Ramsdale,et al.  Acute coronary syndrome: ST segment elevation myocardial infarction , 2003, BMJ : British Medical Journal.

[17]  V. Álvarez,et al.  5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. , 2003, Clinical science.

[18]  R. M. González,et al.  Developmental impairment of auditory evoked N1/P2 component in rats undernourished in utero: its relation to brain serotonin activity. , 2001, Brain research. Developmental brain research.

[19]  K. Gadde,et al.  Central Nervous System Serotonin Function and Cardiovascular Responses to Stress , 2001, Psychosomatic medicine.

[20]  Carmine M Pariante,et al.  Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment , 2001, Biological Psychiatry.

[21]  F. Zhou,et al.  Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. , 1999, Journal of neurophysiology.

[22]  J. Blumenthal,et al.  Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. , 1999, Circulation.

[23]  C. Nemeroff,et al.  The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. , 1998, Archives of general psychiatry.

[24]  G. Karmos,et al.  Auditory-evoked potentials as indicator of brain serotonergic activity first evidence in behaving cats , 1997, Biological Psychiatry.

[25]  C. Nemeroff,et al.  The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. , 1996, Molecular psychiatry.

[26]  M. Schroll,et al.  Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. , 1996, Circulation.

[27]  Georg Juckel,et al.  Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: A new hypothesis , 1993, Biological Psychiatry.

[28]  C. Ehlers,et al.  Long latency event-related potentials in rats: Effects of dopaminergic and serotonergic depletions , 1991, Pharmacology Biochemistry and Behavior.

[29]  L. Deckelbaum,et al.  Myocardial protein turnover in patients with coronary artery disease. Effect of branched chain amino acid infusion. , 1991, The Journal of clinical investigation.

[30]  H. Meltzer.  Role of Serotonin in Depression a , 1990, Annals of the New York Academy of Sciences.

[31]  R. Gorlin,et al.  The nature and course of depression following myocardial infarction. , 1989, Archives of internal medicine.

[32]  B. Josefsson,et al.  Determination of amino acids with 9-fluorenylmethyl chloroformate and reversed-phase high-performance liquid chromatography , 1983 .

[33]  J. Gibb,et al.  High-performance liquid chromatographic determination of indoleamines, dopamine, and norepinephrine in rat brain with fluorometric detection. , 1983, Analytical biochemistry.

[34]  A. Badawy.  The functions and regulation of tryptophan pyrrolase. , 1977, Life sciences.

[35]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[36]  E. Antman,et al.  ST-Segment Elevation Myocardial Infarction , 2012 .

[37]  Monica Leon,et al.  A low brain serotonergic neurotransmission in children with type 1 diabetes detected through the intensity dependence of auditory-evoked potentials. , 2006, Diabetes care.

[38]  B. Jacobs,et al.  Structure and function of the brain serotonin system. , 1992, Physiological reviews.

[39]  L. von Knorring,et al.  Augmenting/reducing: an adaptive switch mechanism to cope with incoming signals in healthy subjects and psychiatric patients. , 1978, Neuropsychobiology.